title: [CME. Biologics in vasculitis].
authors.affiliation: Klinik und Poliklinik für Innere Medizin, Universitätsspital Zürich.
authors.forename: Michael
authors.initials: M
authors.lastname: Scharl
authors.affiliation: Klinik und Poliklinik für Innere Medizin, Universitätsspital Zürich.
authors.forename: Dominik
authors.initials: D
authors.lastname: Schaer
authors.affiliation: Klinik und Poliklinik für Innere Medizin, Universitätsspital Zürich.
authors.forename: Florence
authors.initials: F
authors.lastname: Vallelian
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects / Q000627:therapeutic use; D058846:Antibodies, Monoclonal, Murine-Derived / Q000009:adverse effects / Q000627:therapeutic use; D001249:Asthma / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology; D001688:Biological Products / Q000009:adverse effects / Q000627:therapeutic use*; D015267:Churg-Strauss Syndrome / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology; D005260:Female; D006801:Humans; D000069285:Infliximab; D000069283:Rituximab; D014657:Vasculitis / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D058846:Antibodies, Monoclonal, Murine-Derived; D001688:Biological Products; D000069283:Rituximab; D000069285:Infliximab; C502936:tocilizumab